haloperidol and Dementia
haloperidol has been researched along with Dementia in 102 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"When comparing treatment effects on individual symptoms frequently occurring in patients with dementia, risperidone significantly improved symptoms of agitation, wandering, diurnal rhythm disturbance and anxieties, among other symptoms, compared with haloperidol." | 9.12 | Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia. ( Choi, SK; Greenspan, AJ; Suh, GH, 2006) |
"The authors compared the efficacy and side effects of trazodone and haloperidol for treating agitated behaviors associated with dementia." | 9.08 | A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia. ( Berisford, MA; Gray, KF; Gunay, I; Mahler, ME; Sultzer, DL, 1997) |
"The efficacy and safety of risperidone, haloperidol, and thioridazine for treating dementia-associated behavioral disturbances were evaluated in a retrospective study of 186 patients aged 65 years or older with DSM-III-R or DSM-IV diagnoses of Alzheimer's dementia, senile dementia NOS, or organic brain syndrome." | 9.08 | Clinical experience with risperidone, haloperidol, and thioridazine for dementia-associated behavioral disturbances. ( Frenchman, IB; Prince, T, 1997) |
"The therapeutic effects in senile dementia of haloperidol and cis(Z)-clopenthixol were compared in a double-blind, double-dummy clinical 8-week study in 47 demented patients after wash-out periods of 3 weeks or less." | 9.05 | A double-blind comparison of the effects of haloperidol and cis(Z)-clopenthixol in senile dementia. ( Götestam, KG; Ljunghall, S; Olsson, B, 1981) |
"The CDCIG Specialized Register was searched to identify all available reports on haloperidol treatment of agitated dementia." | 8.81 | Haloperidol for agitation in dementia. ( Colford, J; Lonergan, E; Luxenberg, J, 2001) |
" Haloperidol has been used for decades to control agitation in dementia, but its effectiveness remains unclear." | 8.81 | Haloperidol for agitation in dementia. ( Colford, J; Lonergan, E; Luxenberg, J, 2002) |
"The aim of this study was to compare the efficacy and side-effect profile of the typical antipsychotic haloperidol with that of the atypical antipsychotics risperidone, olanzapine, and aripiprazole in the management of delirium." | 7.81 | Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: A comparison of efficacy, safety, and side effects. ( Boettger, S; Breitbart, W; Jenewein, J, 2015) |
"Treatment with haloperidol has been shown, in studies using death certificates and prescription files, to be associated with an excess of sudden cardiac deaths, and regulatory warnings highlight this risk in patients with dementia." | 7.81 | Haloperidol and sudden cardiac death in dementia: autopsy findings in psychiatric inpatients. ( Correll, CU; Grudnikoff, E; Ifteni, P; Kane, JM; Koppel, J; Kremen, N; Manu, P, 2015) |
" Using an optimizing dosage regime, the outcome variables studied were aggression frequency and the number and nature of emergent side effects." | 6.67 | Aggression in the demented patient: a double-blind study of loxapine versus haloperidol. ( Ancill, RJ; Carlyle, W; Sheldon, L, 1993) |
"When comparing treatment effects on individual symptoms frequently occurring in patients with dementia, risperidone significantly improved symptoms of agitation, wandering, diurnal rhythm disturbance and anxieties, among other symptoms, compared with haloperidol." | 5.12 | Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia. ( Choi, SK; Greenspan, AJ; Suh, GH, 2006) |
" In 3 double-blind studies, acutely agitated patients with schizophrenia (N = 311), bipolar mania (N = 201), or dementia (N = 206) were treated with intramuscular (1-3 injections/24 hrs) olanzapine (2." | 5.10 | Calming versus sedative effects of intramuscular olanzapine in agitated patients. ( Alaka, K; Battaglia, J; Lindborg, SR; Meehan, K; Wright, P, 2003) |
" Databases included: placebo-controlled [two schizophrenia, one bipolar mania trials (n=565)]; haloperidol-controlled [two schizophrenia trials (n=482)]; geriatric placebo-controlled [1 dementia trial (n=204)]." | 5.10 | Effects of intramuscular olanzapine vs. haloperidol and placebo on QTc intervals in acutely agitated patients. ( Alaka, K; Beasley, CM; Lindborg, SR; Taylor, CC, 2003) |
"The authors compared the efficacy and side effects of trazodone and haloperidol for treating agitated behaviors associated with dementia." | 5.08 | A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia. ( Berisford, MA; Gray, KF; Gunay, I; Mahler, ME; Sultzer, DL, 1997) |
"The efficacy and safety of risperidone, haloperidol, and thioridazine for treating dementia-associated behavioral disturbances were evaluated in a retrospective study of 186 patients aged 65 years or older with DSM-III-R or DSM-IV diagnoses of Alzheimer's dementia, senile dementia NOS, or organic brain syndrome." | 5.08 | Clinical experience with risperidone, haloperidol, and thioridazine for dementia-associated behavioral disturbances. ( Frenchman, IB; Prince, T, 1997) |
"Fifty-nine elderly residents of long-term care facilities who had DSM-III diagnoses of dementia were studied in an 8-week randomized, double-blind comparison trial of haloperidol, oxazepam, and diphenhydramine to test the efficacy of these agents in the treatment of clinically significant behavioral disturbances in patients with dementia." | 5.06 | Pharmacologic treatment of noncognitive behavioral disturbances in elderly demented patients. ( Coccaro, EF; Duvvi, K; Giordani, B; Kramer, E; Nora, R; Patel, BM; Rice, CM; Thorne, A; Torres, J; Zemishlany, Z, 1990) |
"The therapeutic effects in senile dementia of haloperidol and cis(Z)-clopenthixol were compared in a double-blind, double-dummy clinical 8-week study in 47 demented patients after wash-out periods of 3 weeks or less." | 5.05 | A double-blind comparison of the effects of haloperidol and cis(Z)-clopenthixol in senile dementia. ( Götestam, KG; Ljunghall, S; Olsson, B, 1981) |
"There is a discrepancy in the decisions on the marketing authorization vs the reimbursement in Lithuania and Latvia (reimbursement of haloperidol and trihexyphenidyl for the off-label treatment of dementia)." | 5.01 | Off-Label Use of Antipsychotic Agents in Dementia: Evidence for the Revision of the Reimbursement Policy. ( Jankūnas, RJ; Lesauskaitė, V; Stakišaitis, D; Zamarytė-Sakavičienė, K, 2019) |
"The CDCIG Specialized Register was searched to identify all available reports on haloperidol treatment of agitated dementia." | 4.81 | Haloperidol for agitation in dementia. ( Colford, J; Lonergan, E; Luxenberg, J, 2001) |
" Haloperidol has been used for decades to control agitation in dementia, but its effectiveness remains unclear." | 4.81 | Haloperidol for agitation in dementia. ( Colford, J; Lonergan, E; Luxenberg, J, 2002) |
"The findings of this cohort study suggest that the discontinuation rate of newly initiated APMs for delirium following infection-related hospitalization was lower in atypical APM users than in haloperidol users, with prolonged hospitalization and dementia as major associated variables." | 4.31 | Antipsychotic Medication Use Among Older Adults Following Infection-Related Hospitalization. ( Bessette, LG; Lin, KJ; Wilkins, JM; Wong, V; York, C; Zhang, Y, 2023) |
"The aim of this study was to compare the efficacy and side-effect profile of the typical antipsychotic haloperidol with that of the atypical antipsychotics risperidone, olanzapine, and aripiprazole in the management of delirium." | 3.81 | Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: A comparison of efficacy, safety, and side effects. ( Boettger, S; Breitbart, W; Jenewein, J, 2015) |
"Treatment with haloperidol has been shown, in studies using death certificates and prescription files, to be associated with an excess of sudden cardiac deaths, and regulatory warnings highlight this risk in patients with dementia." | 3.81 | Haloperidol and sudden cardiac death in dementia: autopsy findings in psychiatric inpatients. ( Correll, CU; Grudnikoff, E; Ifteni, P; Kane, JM; Koppel, J; Kremen, N; Manu, P, 2015) |
" Department of Veterans Affairs (fiscal years 1999-2008) for dementia patients age 65 and older who began outpatient treatment with an antipsychotic (risperidone, olanzapine, quetiapine, or haloperidol) or valproic acid and its derivatives (as a nonantipsychotic comparison)." | 3.78 | Risk of mortality among individual antipsychotics in patients with dementia. ( Blow, FC; Chiang, C; Cunningham, F; Kales, HC; Kim, HM; Schneider, LS; Seyfried, LS; Valenstein, M; Zivin, K, 2012) |
"Age, use of opioids, and haloperidol were associated with persistent delirium." | 3.76 | Factors associated with persistent delirium after intensive care unit admission in an older medical patient population. ( Araujo, KL; Murphy, TE; Pisani, MA; Van Ness, PH, 2010) |
"Medical records were reviewed retrospectively to identify consecutive patients who were admitted to our neuropsychiatry service with the presenting complaint of dementia (DSM-IV) with agitation and who were given intramuscular ziprasidone and then administered an electrocardiogram (ECG) (N = 23)." | 3.73 | A retrospective study of the safety of intramuscular ziprasidone in agitated elderly patients. ( Brown, FW; Greco, KE; Tune, LE; Van Horn, WA, 2005) |
"Neuroleptic malignant syndrome occurred in a 71-year-old man on haloperidol therapy for mild depressive dementia." | 3.71 | Neuroleptic malignant syndrome: uncommon postoperative diagnostic dilemma. ( Bhan, S; Kulkarni, V; Mehta, Y; Sharma, KK; Suri, ML; Trehan, N, 2002) |
" This diabetes insipidus is reversible, non-progressive, unrelated to plasma level, and distinct in attack from lithium-induced hypothyroidism, which may occur at low dosage but is also usually of late onset and reversible or treatable with thyroxine while lithium is continued." | 3.65 | Blood levels and management of lithium treatment. ( Crammer, JL; Crane, G; Rosser, RM, 1974) |
" Dosing strategies, discontinuation considerations, and side effects are discussed." | 2.72 | The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An update on management of behavioral and psychological symptoms in dementia. ( Chen, A; Cloutier, A; Copeli, F; Metzger, E; Osser, DN, 2021) |
"Haloperidol was prescribed for 68 percent of the patients." | 2.68 | Neuroleptic treatment of elderly patients. ( Alvir, JM; Kane, JM; Lieberman, JA; Saltz, BL; Woerner, MG, 1995) |
" Using an optimizing dosage regime, the outcome variables studied were aggression frequency and the number and nature of emergent side effects." | 2.67 | Aggression in the demented patient: a double-blind study of loxapine versus haloperidol. ( Ancill, RJ; Carlyle, W; Sheldon, L, 1993) |
"Haloperidol decanoate was thus shown to be therapeutically effective and it can be administered safely to geriatric patients." | 2.65 | Tolerance and serum levels of haloperidol during parenteral and oral haloperidol treatment in geriatric patients. ( Gordin, A; Lamminsivu, U; Salo, H; Viukari, M, 1982) |
"The occurrence of confusion in the elderly patient should alert the physician to the need of investigation to detect underlying severe disease without delay." | 2.39 | [Confusional states in the elderly--an underdiagnosed syndrome with a poor prognosis]. ( Pitkälä, K, 1996) |
"Recently, some cases of neuroleptic malignant syndrome (NMS) in demented patients have been reported, because the demented patients, who were administered neuroleptics due to their abnormal behaviors, have increased." | 2.39 | [Clinical study of neuroleptic malignant syndrome in demented patients--examination of our case and reported cases]. ( Kimura, T; Yoshida, H, 1994) |
" As a group, the atypical antipsychotics (olanzapine, quetiapine, and risperidone) showed a dose-response increase in mortality risk, with 3." | 1.42 | Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm. ( Chiang, C; Kales, HC; Kavanagh, J; Kim, HM; Maust, DT; Schneider, LS; Seyfried, LS, 2015) |
"Haloperidol was associated with higher mortality risk (HR 30 days = 1." | 1.40 | Short- and long-term mortality risk associated with the use of antipsychotics among 26,940 dementia outpatients: a population-based study. ( Aarsland, D; Ballard, C; Engdahl, B; Langballe, EM; Nordeng, H; Selbæk, G, 2014) |
" There was a dose-response relation for all drugs except quetiapine." | 1.38 | Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study. ( Avorn, J; Crystal, S; Gerhard, T; Huybrechts, KF; Levin, R; Lucas, JA; Olfson, M; Schneeweiss, S, 2012) |
" Further investigations are warranted to identify patient characteristics and antipsychotic dosage regimens that are not associated with a greater risk of mortality in elderly patients with dementia." | 1.36 | Are all commonly prescribed antipsychotics associated with greater mortality in elderly male veterans with dementia? ( Dysken, MW; Lederle, FA; Rector, TS; Rossom, RC, 2010) |
"Constipation was very troublesome and he often needed enema to prevent intestinal obstruction." | 1.34 | Minimizing antipsychotic medication obviated the need for enema against severe constipation leading to paralytic ileus: a case report. ( Kashima, H; Suzuki, T; Uchida, H; Watanabe, K, 2007) |
"The pattern of myoclonus is unlike previous reported cases and may relate to activation of serotonin 5HT1A receptors (possibly supersensitive in Pick's disease) or to hypodopaminergia." | 1.29 | Reversible intermittent rhythmic myoclonus with fluoxetine in presumed Pick's disease. ( Lauterbach, EC, 1994) |
Research
Studies (102)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 37 (36.27) | 18.7374 |
1990's | 19 (18.63) | 18.2507 |
2000's | 27 (26.47) | 29.6817 |
2010's | 16 (15.69) | 24.3611 |
2020's | 3 (2.94) | 2.80 |
Authors
Authors | Studies |
---|---|
Kołaczkowski, M | 4 |
Marcinkowska, M | 4 |
Bucki, A | 4 |
Pawłowski, M | 4 |
Mitka, K | 1 |
Jaśkowska, J | 1 |
Kowalski, P | 1 |
Kazek, G | 2 |
Siwek, A | 4 |
Wasik, A | 2 |
Wesołowska, A | 4 |
Mierzejewski, P | 4 |
Bienkowski, P | 2 |
Śniecikowska, J | 3 |
Jastrzębska-Więsek, M | 3 |
Partyka, A | 3 |
Więckowski, K | 1 |
Głuch-Lutwin, M | 2 |
Gryboś, A | 1 |
Pytka, K | 2 |
Zagórska, A | 1 |
Jamrozik, M | 1 |
Jakubczyk, M | 1 |
Zhang, Y | 1 |
Wilkins, JM | 1 |
Bessette, LG | 1 |
York, C | 1 |
Wong, V | 1 |
Lin, KJ | 1 |
Chen, A | 1 |
Copeli, F | 1 |
Metzger, E | 1 |
Cloutier, A | 1 |
Osser, DN | 2 |
Nerius, M | 1 |
Johnell, K | 1 |
Garcia-Ptacek, S | 1 |
Eriksdotter, M | 1 |
Haenisch, B | 1 |
Doblhammer, G | 1 |
Stakišaitis, D | 1 |
Zamarytė-Sakavičienė, K | 1 |
Lesauskaitė, V | 1 |
Jankūnas, RJ | 1 |
O'Regan, NA | 1 |
Mohamad, MM | 1 |
Meagher, DJ | 1 |
Vilibić, M | 1 |
Jukić, V | 1 |
Vidović, A | 1 |
Brecić, P | 1 |
Gurwitz, D | 1 |
Morag, A | 1 |
Oved, K | 1 |
Langballe, EM | 1 |
Engdahl, B | 1 |
Nordeng, H | 1 |
Ballard, C | 1 |
Aarsland, D | 2 |
Selbæk, G | 1 |
Boettger, S | 1 |
Jenewein, J | 1 |
Breitbart, W | 1 |
Maust, DT | 1 |
Kim, HM | 2 |
Seyfried, LS | 2 |
Chiang, C | 2 |
Kavanagh, J | 1 |
Schneider, LS | 2 |
Kales, HC | 2 |
Ifteni, P | 1 |
Grudnikoff, E | 1 |
Koppel, J | 1 |
Kremen, N | 1 |
Correll, CU | 1 |
Kane, JM | 2 |
Manu, P | 1 |
Forlenza, OV | 1 |
Cretaz, E | 1 |
Diniz, BS | 1 |
Koch, HJ | 1 |
Nanev, D | 1 |
Becker, K | 1 |
Pisani, MA | 1 |
Murphy, TE | 1 |
Araujo, KL | 1 |
Van Ness, PH | 1 |
Rossom, RC | 1 |
Rector, TS | 1 |
Lederle, FA | 1 |
Dysken, MW | 1 |
Zivin, K | 1 |
Valenstein, M | 1 |
Cunningham, F | 1 |
Blow, FC | 1 |
Huybrechts, KF | 1 |
Gerhard, T | 1 |
Crystal, S | 1 |
Olfson, M | 1 |
Avorn, J | 1 |
Levin, R | 1 |
Lucas, JA | 1 |
Schneeweiss, S | 1 |
Bhan, S | 1 |
Kulkarni, V | 1 |
Mehta, Y | 1 |
Sharma, KK | 1 |
Trehan, N | 1 |
Suri, ML | 1 |
Battaglia, J | 1 |
Lindborg, SR | 2 |
Alaka, K | 2 |
Meehan, K | 1 |
Wright, P | 1 |
Beasley, CM | 1 |
Taylor, CC | 1 |
GERLE, B | 1 |
BUIS, C | 1 |
FLOHIL, JM | 1 |
SUGERMAN, AA | 1 |
WILLIAMS, BH | 1 |
ADLERSTEIN, AM | 1 |
Warner, J | 1 |
Butler, R | 1 |
Arya, P | 1 |
Greco, KE | 1 |
Tune, LE | 1 |
Brown, FW | 1 |
Van Horn, WA | 1 |
Suaudeau, C | 1 |
do-Rego, JC | 1 |
Costentin, J | 1 |
Finkel, S | 1 |
Kozma, C | 1 |
Long, S | 1 |
Greenspan, A | 1 |
Mahmoud, R | 1 |
Baser, O | 1 |
Engelhart, L | 1 |
Peitl, A | 1 |
Vucić Peitl, M | 1 |
Pavlović, E | 1 |
Ljubicić, D | 1 |
Suh, GH | 2 |
Greenspan, AJ | 2 |
Choi, SK | 2 |
Zuidema, SU | 1 |
van Iersel, MB | 1 |
Koopmans, RT | 1 |
Verhey, FR | 1 |
Olde Rikkert, MG | 1 |
Nassisi, D | 1 |
Korc, B | 1 |
Hahn, S | 1 |
Bruns, J | 1 |
Jagoda, A | 1 |
Jackson, GA | 1 |
Suzuki, T | 1 |
Uchida, H | 1 |
Watanabe, K | 1 |
Kashima, H | 1 |
Hollis, J | 1 |
Grayson, D | 1 |
Forrester, L | 1 |
Brodaty, H | 1 |
Touyz, S | 1 |
Cumming, R | 1 |
Preskorn, SH | 1 |
Ruths, S | 1 |
Straand, J | 1 |
Nygaard, HA | 1 |
Füessl, HS | 1 |
Selbaek, G | 1 |
Engedal, K | 1 |
Allen, RM | 1 |
Barbosa, ER | 1 |
Marchiori, PE | 1 |
Scaff, M | 1 |
de Assis, JL | 1 |
Götestam, KG | 1 |
Ljunghall, S | 1 |
Olsson, B | 1 |
Petrie, WM | 1 |
Ban, TA | 2 |
Berney, S | 1 |
Fujimori, M | 1 |
Guy, W | 1 |
Ragheb, M | 1 |
Wilson, WH | 1 |
Schaffer, JD | 1 |
Viukari, M | 1 |
Salo, H | 1 |
Lamminsivu, U | 1 |
Gordin, A | 1 |
Busch, KT | 1 |
Schulz, H | 1 |
Risberg, J | 1 |
Woerner, MG | 1 |
Alvir, JM | 1 |
Saltz, BL | 1 |
Lieberman, JA | 1 |
McSwain, ML | 1 |
Forman, LM | 1 |
Kimura, T | 1 |
Yoshida, H | 1 |
Lauterbach, EC | 1 |
Brock, G | 1 |
Gurekas, VL | 1 |
Thomas, JE | 1 |
Carlyle, W | 1 |
Ancill, RJ | 1 |
Sheldon, L | 1 |
Mowadat, HR | 1 |
Kerr, EE | 1 |
StClair, D | 1 |
Pitkälä, K | 1 |
Chang, WH | 1 |
Jann, MW | 1 |
Chiang, TS | 1 |
Lin, HN | 1 |
Hu, WH | 1 |
Chien, CP | 1 |
Sunderland, T | 1 |
Maany, I | 1 |
Auer, SR | 1 |
Monteiro, IM | 1 |
Reisberg, B | 1 |
Sultzer, DL | 1 |
Gray, KF | 1 |
Gunay, I | 1 |
Berisford, MA | 1 |
Mahler, ME | 1 |
Manos, PJ | 1 |
Wu, R | 1 |
Frenchman, IB | 1 |
Prince, T | 1 |
MacLennan, WJ | 1 |
De Deyn, PP | 2 |
Rabheru, K | 1 |
Rasmussen, A | 1 |
Bocksberger, JP | 1 |
Dautzenberg, PL | 1 |
Eriksson, S | 1 |
Lawlor, BA | 1 |
Windhaber, J | 1 |
Urbanits, S | 1 |
Grisold, W | 1 |
Katz, IR | 1 |
Maruka, Y | 1 |
Esumi, E | 1 |
Kojima, S | 1 |
Lonergan, E | 2 |
Luxenberg, J | 2 |
Colford, J | 2 |
Fine, F | 1 |
Walker, DJ | 1 |
ter Haar, HW | 1 |
Cowley, LM | 1 |
Glen, RS | 1 |
Pecknold, JC | 1 |
Silverman, G | 1 |
Thornton, WE | 1 |
Yudofsky, SC | 1 |
Silver, JM | 1 |
Hales, RE | 1 |
Coccaro, EF | 1 |
Kramer, E | 1 |
Zemishlany, Z | 1 |
Thorne, A | 1 |
Rice, CM | 1 |
Giordani, B | 1 |
Duvvi, K | 1 |
Patel, BM | 1 |
Torres, J | 1 |
Nora, R | 1 |
Kellner, CH | 1 |
Melvin, JA | 1 |
Hermesh, H | 1 |
Sirota, P | 1 |
Eviatar, J | 1 |
Janati, A | 1 |
Herrmann, N | 1 |
Lieff, SJ | 1 |
Stewart, TD | 1 |
Lovett, WC | 1 |
Stokes, DK | 1 |
Taylor, LB | 1 |
Young, ML | 1 |
Free, SM | 1 |
Phelan, DG | 1 |
Ciccone, PE | 1 |
Fayer, SA | 1 |
Ekbom, K | 1 |
Lindholm, H | 1 |
Ljungberg, L | 1 |
Walsh, AC | 1 |
Walsh, BH | 1 |
Rosin, AJ | 1 |
Crammer, JL | 1 |
Rosser, RM | 1 |
Crane, G | 1 |
Vangtorp, A | 1 |
Simmelsgaard, H | 1 |
Mellegaard, M | 1 |
Tobin, JM | 1 |
Brousseau, ER | 1 |
Lorenz, AA | 1 |
Tewfik, GI | 1 |
Jain, VK | 1 |
Harcup, M | 1 |
Magowan, S | 1 |
Tsuang, MM | 1 |
Lu, LM | 1 |
Stotsky, BA | 1 |
Cole, JO | 1 |
Helmchen, H | 1 |
Vallecorsi, G | 1 |
Bavazzano, A | 1 |
Radzuweit, H | 1 |
Knorr, W | 1 |
Buffa, B | 1 |
Cotta Ramusino, M | 1 |
Muti, M | 1 |
Clinical Trials (4)
Trial Overview
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Feru-guard (Ferulic Acid and Angelica Archangelica Extract) for Behavioral Symptoms in Dementia[NCT03451760] | Phase 2 | 70 participants (Anticipated) | Interventional | 2018-09-30 | Not yet recruiting | ||
Risperidone in the Treatment of Behavioral Disturbances in Demented Patients: an International, Multicenter, Placebo-controlled, Double-blind, Parallel-group Trial Using Haloperidol as Internal Reference[NCT00249145] | Phase 3 | 349 participants (Actual) | Interventional | 1995-04-30 | Completed | ||
Elderly Patients With Dementia in the Department of Acute Geriatrics: Pilot Study, Monocentric, Randomized Use of Aromatherapy as a Complementary Treatment to Psychopharmacotherapy in Psychological Disorders and BPSD Behavior[NCT03662360] | 32 participants (Actual) | Interventional | 2018-05-20 | Completed | |||
TRANSCRANIAL DIRECT CURRENT STIMULATION (t-DCS) AS ADD-ON TO NEUROREHABILITATION OF PISA SYNDROME IN PARKINSON DISEASE: A RANDOMIZED CONTROLLED TRIAL[NCT04620863] | 30 participants (Actual) | Interventional | 2019-01-15 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Trial Outcomes
Role of Essential Oil Therapy in Environmental Diffusion as a Complement of Psychotropic Drugs in the Management of Psychological and Behavioral Disorders (BPSD)
"The Neuropsychiatric Inventory - Nursing Home Version (NPI-NH) test will characterize the neuropsychiatric and psychopathological symptoms of patients affected by dementia.~Events as delirium, anxiety, depression, etc. will be recorded by the frequency (from 0, absence, to 4, high frequency) and the seriousness (from 0, absence, to 3, high). The total score of the NPI-NH is given by the frequency x (multiply) seriousness (total score for each event has a range from 0 to 12). The patient final score will be given by the sum of the score of the 12 events. For each patient will be given a total score from 0 to 144.~NPI NH score has been collected in both control and aromatherapy groups at T1 and T3, in patients who needed and who did not needed Pro Re Nata." (NCT03662360)
Timeframe: Time 1 (baseline) and Time 3 (day 7)
Intervention | score on a scale (Mean) | ||
---|---|---|---|
T1 NPI score in patients do not need Pro Re Nata | T3 NPI score in patients needed Pro Re Nata | T3 NPI score in patients do not need Pro Re Nata | |
GROUP A - Control Group | 21.81 | 32.87 | 20.00 |
GROUP B - Aromatherapy Group | 25.93 | 16.5 | 7.25 |
Role of Essential Oil Therapy in Environmental Diffusion in Professional Caregiver Distress Linked to BPSD
NPI-NH assess the psychological distress in physicians, nurses and nursing assistants who managed the patients. It has a score from 0 (no discomfort) to score of 5 (extreme discomfort). The psychological distress is measured for each of the 12 events in the NPI-NH scale, for a total score from 0 to 60. (NCT03662360)
Timeframe: Time 1 (baseline) and Time 3 (day 7)
Intervention | score on a scale (Mean) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
T1 NPI NH physicians in pts with PRN | T1 NPI NH physicians in pts without PRN | T1 NPI NH nurses in pts with PRN | T1 NPI NH nurses in pts without PRN | T1 NPI NH nursing assistants in pts with PRN | T1 NPI NH nursing assistants in pts without PRN | T3 NPI NH physician in pts with PRN | T3 NPI NH physician in pts without PRN | T3 NPI NH nurses in pts with PRN | T3 NPI NH nurses in pts without PRN | T3 NPI NH nursing assistants in pts with PRN | T3 NPI NH nursing assistants in pts without PRN | |
GROUP A - Control Group | 4.19 | 1.60 | 9.63 | 6.40 | 11.00 | 7.10 | 6.00 | 3.20 | 12.00 | 9.30 | 13.19 | 9.90 |
GROUP B - Aromatherapy Group | 5.64 | 4.13 | 11.64 | 10.13 | 12.21 | 10.88 | 2.64 | 0.88 | 5.79 | 4.25 | 5.93 | 4.38 |
Reviews
15 reviews available for haloperidol and Dementia
Article | Year |
---|---|
The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An update on management of behavioral and psychological symptoms in dementia.
Topics: Academic Medical Centers; Aged; Algorithms; Antidepressive Agents; Antipsychotic Agents; Aripiprazol | 2021 |
Off-Label Use of Antipsychotic Agents in Dementia: Evidence for the Revision of the Reimbursement Policy.
Topics: Antipsychotic Agents; Dementia; European Union; Haloperidol; Humans; Insurance, Health, Reimbursemen | 2019 |
[The use of antipsychotics in patients with dementia].
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cerebrovascular Disorders; Dementia; Dementia, | 2008 |
Dementia.
Topics: Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Cognition; Dementia; Donepezil; Galantamin | 2004 |
[Efficacy and adverse reactions of antipsychotics for neuropsychiatric symptoms in dementia: a systematic review].
Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Dementia; Haloperidol; Humans; Olanzapine; Psycho | 2006 |
The evaluation and management of the acutely agitated elderly patient.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Dementia; Diagnosis, Differential; Drug Therapy, Combin | 2006 |
[Clinical study of neuroleptic malignant syndrome in demented patients--examination of our case and reported cases].
Topics: Aged; Aged, 80 and over; Dementia; Dementia, Vascular; Female; Haloperidol; Humans; Male; Middle Age | 1994 |
[Confusional states in the elderly--an underdiagnosed syndrome with a poor prognosis].
Topics: Aged; Comorbidity; Confusion; Delirium; Dementia; Diagnosis, Differential; Haloperidol; Humans; Neur | 1996 |
Treatment of the elderly suffering from psychosis and dementia.
Topics: Age Factors; Aged; Alzheimer Disease; Antipsychotic Agents; Buspirone; Clinical Trials as Topic; Dem | 1996 |
Confusion: the cause is the key.
Topics: Aged; Confusion; Dementia; Haloperidol; Humans; Hypnotics and Sedatives; Thioridazine | 1999 |
Control of aggression and agitation in patients with dementia: efficacy and safety of risperidone.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Canada; Dementia; Dose-Response Relationship, Drug; D | 2000 |
Haloperidol for agitation in dementia.
Topics: Aggression; Anti-Dyskinesia Agents; Dementia; Haloperidol; Humans; Psychomotor Agitation; Randomized | 2001 |
Haloperidol for agitation in dementia.
Topics: Aggression; Anti-Dyskinesia Agents; Dementia; Haloperidol; Humans; Psychomotor Agitation; Randomized | 2002 |
Haloperidol in the therapy of severe behavior disorders.
Topics: Benperidol; Bipolar Disorder; Child Behavior; Dementia; Droperidol; Haloperidol; Humans; Neurocognit | 1976 |
Pharmacologic management of aggression in the elderly.
Topics: Aged; Aggression; Antipsychotic Agents; Benzodiazepines; Buspirone; Dementia; Haloperidol; Humans; L | 1990 |
Trials
21 trials available for haloperidol and Dementia
Article | Year |
---|---|
Calming versus sedative effects of intramuscular olanzapine in agitated patients.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dementia; Doubl | 2003 |
Effects of intramuscular olanzapine vs. haloperidol and placebo on QTc intervals in acutely agitated patients.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dementia; Dose-Response Relationship, Drug; | 2003 |
Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Anxiety Disorders; Cross-Over Studies; Dementia; Doub | 2006 |
Stopping antipsychotic drug therapy in demented nursing home patients: a randomized, placebo-controlled study--the Bergen District Nursing Home Study (BEDNURS).
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Dementia; Double-Blind Method; Femal | 2008 |
A double-blind comparison of the effects of haloperidol and cis(Z)-clopenthixol in senile dementia.
Topics: Aged; Clinical Trials as Topic; Clopenthixol; Dementia; Double-Blind Method; Female; Haloperidol; Hu | 1981 |
Loxapine in psychogeriatrics: a placebo- and standard-controlled clinical investigation.
Topics: Aged; Clinical Trials as Topic; Dementia; Dibenzoxazepines; Double-Blind Method; Female; Haloperidol | 1982 |
Tolerance and serum levels of haloperidol during parenteral and oral haloperidol treatment in geriatric patients.
Topics: Administration, Oral; Aged; Delayed-Action Preparations; Dementia; Drug Tolerance; Female; Haloperid | 1982 |
Neuroleptic treatment of elderly patients.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Brief Psychiatric Rating Scale; Dementia; Depressive | 1995 |
Aggression in the demented patient: a double-blind study of loxapine versus haloperidol.
Topics: Aged; Aged, 80 and over; Aggression; Alzheimer Disease; Basal Ganglia Diseases; Dementia; Dementia, | 1993 |
Behavioral symptoms in dementia: community-based research.
Topics: Aged; Alzheimer Disease; Ambulatory Care; Antipsychotic Agents; Dementia; Double-Blind Method; Femal | 1996 |
A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Dementia; D | 1997 |
Clinical experience with risperidone, haloperidol, and thioridazine for dementia-associated behavioral disturbances.
Topics: Aged; Antipsychotic Agents; Chi-Square Distribution; Dementia; Haloperidol; Humans; Retrospective St | 1997 |
A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia.
Topics: Aged; Aged, 80 and over; Behavior; Dementia; Double-Blind Method; Female; Haloperidol; Humans; Male; | 1999 |
The relief of restlessness in the elderly.
Topics: Activities of Daily Living; Aged; Chlormethiazole; Clinical Trials as Topic; Cognition; Confusion; D | 1977 |
Double-blind study of thioridazine and haloperidol in geriatric patients with a psychosis associated with organic brain syndrome.
Topics: Aged; Blood Pressure; Dementia; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; | 1979 |
Pharmacologic treatment of noncognitive behavioral disturbances in elderly demented patients.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Diphenhydramine; D | 1990 |
Management of behavioral symptoms in disturbed elderly patients: comparison of trifluoperazine and haloperidol.
Topics: Aged; Aged, 80 and over; Clinical Trials as Topic; Dementia; Double-Blind Method; Female; Haloperido | 1987 |
Experience with a new butyrophenone derivative (Buronil).
Topics: Aged; Butyrophenones; Clinical Trials as Topic; Dementia; Female; Haloperidol; Humans; Male; Promazi | 1968 |
Clinical evaluation of haloperidol in geriatric patients.
Topics: Aged; Clinical Trials as Topic; Dementia; Haloperidol; Humans; Psychomotor Disorders; Psychopharmaco | 1970 |
Effectiveness of various tranquilisers in the management of senile restlessness.
Topics: Aged; Carbamates; Chlorpromazine; Clinical Trials as Topic; Dementia; Female; Haloperidol; Humans; H | 1970 |
Haloperidol versus thioridazine for hospitalized psychogeriatric patients: double-blind study.
Topics: Activities of Daily Living; Aged; Clinical Trials as Topic; Dementia; Electrocardiography; Female; H | 1971 |
Other Studies
66 other studies available for haloperidol and Dementia
Article | Year |
---|---|
Novel arylsulfonamide derivatives with 5-HT₆/5-HT₇ receptor antagonism targeting behavioral and psychological symptoms of dementia.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Avoidance Learning; Benzoxazoles; Catalepsy; C | 2014 |
Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia.
Topics: Animals; Benzamides; Dementia; Dose-Response Relationship, Drug; Drug Partial Agonism; Humans; Indol | 2015 |
Novel 3-(1,2,3,6-Tetrahydropyridin-4-yl)-1H-indole-Based Multifunctional Ligands with Antipsychotic-Like, Mood-Modulating, and Procognitive Activity.
Topics: Affect; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Dementia; Dopamine Agonist | 2017 |
Multifunctional 6-fluoro-3-[3-(pyrrolidin-1-yl)propyl]-1,2-benzoxazoles targeting behavioral and psychological symptoms of dementia (BPSD).
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Benzoxazoles; Dementia; Dizocilpine Maleate; Dose-R | 2020 |
Antipsychotic Medication Use Among Older Adults Following Infection-Related Hospitalization.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Cohort Studies; Delirium; Dementia; Female; Ha | 2023 |
The Impact of Antipsychotic Drugs on Long-term Care, Nursing Home Admission, and Death in Dementia Patients.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Butyrophenones; Cohort Studies; Dementia; Female; Ger | 2018 |
Impact of an educational workshop upon psychiatrists' attitudes towards delirium care.
Topics: Aged; Attitude of Health Personnel; Delirium; Dementia; Diagnosis, Differential; Haloperidol; Humans | 2019 |
Cobalamin deficiency manifested with seizures, mood oscillations, psychotic features and reversible dementia in the absence of typical neurologic and hematologic signs and symptoms: a case report.
Topics: Carbamazepine; Dementia; Diazepam; Electroencephalography; Haloperidol; Hematology; Humans; Hydroxoc | 2013 |
A biological basis for the sex bias of antipsychotic drugs adverse events.
Topics: Aged; Antipsychotic Agents; Cell Line; Cell Proliferation; Dementia; Dose-Response Relationship, Dru | 2013 |
Short- and long-term mortality risk associated with the use of antipsychotics among 26,940 dementia outpatients: a population-based study.
Topics: Aged; Aged, 80 and over; Ambulatory Care; Antipsychotic Agents; Cohort Studies; Dementia; Female; Ha | 2014 |
Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: A comparison of efficacy, safety, and side effects.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Delirium; Dementia; Female; Haloperidol; | 2015 |
Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.
Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Dementia; | 2015 |
Haloperidol and sudden cardiac death in dementia: autopsy findings in psychiatric inpatients.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Autopsy; Death, Sudden, Cardiac; Dementia; Female; Ha | 2015 |
[Acute behaviour disorder in a patient with X-linked hydrocephalus with normal pressure].
Topics: Antipsychotic Agents; Bisoprolol; Dementia; Drug Therapy, Combination; Gait Disorders, Neurologic; G | 2009 |
Risperidone and dementia-related aggression: new indication. A last resort, no better than haloperidol.
Topics: Aged; Aggression; Alzheimer Disease; Antipsychotic Agents; Dementia; Drug Approval; Europe; France; | 2009 |
Factors associated with persistent delirium after intensive care unit admission in an older medical patient population.
Topics: Age Factors; Aged; Analgesics, Opioid; Analysis of Variance; Critical Care; Delirium; Dementia; Halo | 2010 |
Are all commonly prescribed antipsychotics associated with greater mortality in elderly male veterans with dementia?
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Comorbidity; Dementi | 2010 |
Risk of mortality among individual antipsychotics in patients with dementia.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Dementia; Dibenzothiazepines; Female | 2012 |
Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Cause of Death; Comorbidity; Dementia; Dibenzothiazep | 2012 |
Neuroleptic malignant syndrome: uncommon postoperative diagnostic dilemma.
Topics: Aged; Bromocriptine; Coronary Artery Bypass; Coronary Artery Disease; Dementia; Diagnosis, Different | 2002 |
[CLINICAL ASPECTS OF HALOPERIDOL].
Topics: Dementia; Geriatrics; Haloperidol; Injections, Intramuscular; Mental Disorders; Neurotic Disorders; | 1964 |
[CLINICAL EXPERIENCES WITH HALOPERIDOL (SERENASE)].
Topics: Bipolar Disorder; Chlorpromazine; Chorea; Dementia; Depressive Disorder, Major; Epilepsy; Haloperido | 1964 |
HALOPERIDOL IN THE PSYCHIATRIC DISORDERS OF OLD AGE.
Topics: Biomedical Research; Dementia; Geriatrics; Haloperidol; Intracranial Arteriosclerosis; Mental Disord | 1964 |
A retrospective study of the safety of intramuscular ziprasidone in agitated elderly patients.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Arrhythmias, Cardiac; Dementia; Electrocardiography; | 2005 |
Modifications in avoidance reactions of mice, on a second exposure to the hot plate, resist to various amnesia-inducing treatments.
Topics: Analysis of Variance; Animals; Anticonvulsants; Avoidance Learning; Behavior, Animal; Dementia; Diaz | 2005 |
Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Cerebrovascular Disorders; Cohort St | 2005 |
Acute brain syndrome as a consequence of the Cronkhite-Canada syndrome.
Topics: Acute Disease; Aged; Dementia; Drug Therapy, Combination; Female; Haloperidol; Humans; Intestinal Po | 2005 |
Assertion that risperidone is superior to haloperidol for treatment of behavioural and psychological symptoms of dementia.
Topics: Antipsychotic Agents; Dementia; Haloperidol; Humans; Risperidone; Therapeutic Equivalency | 2007 |
Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
Topics: Aged; Antipsychotic Agents; Dementia; Dose-Response Relationship, Drug; Double-Blind Method; Haloper | 2007 |
Minimizing antipsychotic medication obviated the need for enema against severe constipation leading to paralytic ileus: a case report.
Topics: Aged; Antipsychotic Agents; Constipation; Dementia; Dose-Response Relationship, Drug; Drug Therapy, | 2007 |
Antipsychotic medication dispensing and risk of death in veterans and war widows 65 years and older.
Topics: Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Antipsychotic Agents; Australia; Benzodiazepi | 2007 |
Multiple medication use presenting as Parkinson's dementia complex: a message from Titanic.
Topics: Aged; Anti-Infective Agents; Antiparkinson Agents; Antipsychotic Agents; Bacteriuria; Ciprofloxacin; | 2008 |
[Delirium in the old age].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antipsychotic Agents; Delirium; Dementia; Diagnosis, | 2008 |
[Atypical antipsychotics in elderly patients with dementia].
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Dementia; Haloperidol; Humans; Metho | 2008 |
Palliative treatment of tardive dyskinesia with combination of amantadine-neuroleptic administration.
Topics: Adult; Aged; Amantadine; Antipsychotic Agents; Dementia; Dose-Response Relationship, Drug; Drug Ther | 1982 |
[Huntington chorea: report of 16 cases].
Topics: Adult; Aged; Brain Diseases; Chlorpromazine; Dementia; Diagnosis, Differential; Female; gamma-Aminob | 1983 |
Clinical conferences: Management of depression in older people.
Topics: Aged; Antidepressive Agents; Dementia; Depressive Disorder; Desipramine; Diagnosis, Differential; Do | 1982 |
[The acute psychiatric emergency].
Topics: Acute Disease; Aged; Alcoholism; Amitriptyline; Brain Ischemia; Cognition Disorders; Consciousness D | 1981 |
Regional cerebral blood flow measurements by 133Xe-inhalation: methodology and applications in neuropsychology and psychiatry.
Topics: Adult; Affective Symptoms; Aged; Alcoholism; Cerebrovascular Circulation; Computers; Dementia; Femal | 1980 |
Severe parkinsonian symptom development on combination treatment with tacrine and haloperidol.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Dementia; Drug Therapy, Combination; Haloperidol; Hum | 1995 |
Reversible intermittent rhythmic myoclonus with fluoxetine in presumed Pick's disease.
Topics: Affective Disorders, Psychotic; Brain; Dementia; Dose-Response Relationship, Drug; Electroencephalog | 1994 |
The jumpy janitor. Letter to an ethicist.
Topics: Aged; Aggression; Dementia; Ethics, Medical; Haloperidol; Humans; Inpatients; Long-Term Care; Male; | 1993 |
Sporadic Pick's disease in a 28-year-old woman.
Topics: Adult; Atrophy; Carbamazepine; Dementia; Electroconvulsive Therapy; Female; Frontal Lobe; Haloperido | 1993 |
Plasma haloperidol and reduced haloperidol concentrations in a geriatric population.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Bipolar Disorder; Dementia; Dose- | 1996 |
Adverse interaction of tacrine and haloperidol.
Topics: Aged; Dementia; Drug Interactions; Drug Therapy, Combination; Female; Haloperidol; Humans; Parkinson | 1996 |
The duration of delirium in medical and postoperative patients referred for psychiatric consultation.
Topics: Aged; Delirium; Dementia; Female; Haloperidol; Humans; Length of Stay; Male; Middle Aged; Patient Ca | 1997 |
Neurologic side effects in neuroleptic-naïve patients treated with haloperidol or risperidone.
Topics: Aged; Antipsychotic Agents; Basal Ganglia Diseases; Dementia; Dose-Response Relationship, Drug; Halo | 2000 |
Tandospirone, a promising alternative drug in the treatment of chorea.
Topics: Animals; Atrophy; Cerebral Cortex; Chorea; Dementia; Dopamine Antagonists; Female; Fluvoxamine; Halo | 2000 |
Management of the elderly agitated demented patient.
Topics: Aged; Anti-Anxiety Agents; Dementia; Drug Combinations; Haloperidol; Humans; Lorazepam; Trihexypheni | 1977 |
Management of the elderly agitated demented patient.
Topics: Aged; Dementia; Haloperidol; Humans | 1977 |
Dementia induced by methyldopa with haloperidol.
Topics: Adult; Anxiety; Dementia; Drug Synergism; Haloperidol; Humans; Hypertension; Male; Methyldopa; Middl | 1976 |
Neuroleptic malignant syndrome associated with basal ganglia hemorrhage.
Topics: Aged; Basal Ganglia; Basal Ganglia Diseases; Cerebral Hemorrhage; Dementia; Haloperidol; Humans; Mal | 1989 |
Recurrent neuroleptic malignant syndrome due to haloperidol and amantadine.
Topics: Aged; Amantadine; Dementia; Drug Therapy, Combination; Haloperidol; Humans; Male; Neuroleptic Malign | 1989 |
Kluver-Bucy syndrome in Huntington's chorea.
Topics: Adult; Agnosia; Behavior; Dementia; Dopamine; Feeding Behavior; Haloperidol; Humans; Huntington Dise | 1985 |
Drug-induced catatonia.
Topics: Aged; Aged, 80 and over; Catatonia; Dementia; Depressive Disorder; Drug Therapy, Combination; Female | 1988 |
Agitation associated with dementia: neuroleptic malignant syndrome and fatal outcome in an 84-year-old man.
Topics: Aged; Aged, 80 and over; Dementia; Dose-Response Relationship, Drug; Haloperidol; Humans; Male; Neur | 1988 |
Effectiveness of neuroleptics on behavioral symptoms in disturbed elderly patients.
Topics: Aged; Dementia; Haloperidol; Humans; Neurocognitive Disorders; Trifluoperazine | 1987 |
Torsades de pointes ventricular tachyarrhythmia associated with haloperidol.
Topics: Aged; Dementia; Female; Haloperidol; Humans; Tachycardia | 1986 |
New dystonic syndrome associated with butyrophenone therapy.
Topics: Amines; Antiparkinson Agents; Basal Ganglia; Butyrophenones; Dementia; Female; Gait; Haloperidol; Hu | 1972 |
Presenile dementia: further experience with an anticoagulant-psychotherapy regimen.
Topics: Adult; Aged; Anticoagulants; Anxiety; Atrophy; Brain Diseases; Dementia; Dicumarol; Fear; Female; Ha | 1974 |
Clinical features, etiology and treatment of facial dyskinesias in the elderly.
Topics: Age Factors; Aged; Brain; Brain Damage, Chronic; Brain Stem; Chorea; Dementia; Dopamine; Face; Femal | 1974 |
Blood levels and management of lithium treatment.
Topics: Administration, Oral; Adult; Aged; Carbimazole; Delayed-Action Preparations; Dementia; Depression; D | 1974 |
[Psychopharmacological agents in treatment of psychiatric emergencies].
Topics: Adult; Age Factors; Aged; Antidepressive Agents; Dementia; Diazepam; Haloperidol; Humans; Hypnotics | 1971 |
[Haloperidol in the treatment of mental confusion in the aged].
Topics: Aged; Cognition Disorders; Dementia; Female; Haloperidol; Humans; Male; Psychomotor Disorders | 1971 |
[Influencing of biological and immunologic pregnancy reactions by psychotropic drugs].
Topics: Adolescent; Adult; Aged; Butyrophenones; Chlorpromazine; Dementia; Depressive Disorder, Major; Dysau | 1969 |
[Haloperidol in states of psychomotor excitation and in anxiety states secondary to acute cardiocirculatory insufficiency].
Topics: Aged; Anxiety Disorders; Coronary Disease; Dementia; Female; Haloperidol; Heart Diseases; Humans; Hy | 1966 |